Doximity, Inc. $DOCS Stock Position Raised by Bayforest Capital Ltd

Bayforest Capital Ltd lifted its stake in Doximity, Inc. (NASDAQ:DOCS) by 162.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,614 shares of the company’s stock after acquiring an additional 6,565 shares during the period. Bayforest Capital Ltd’s holdings in Doximity were worth $616,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in DOCS. VSM Wealth Advisory LLC acquired a new stake in shares of Doximity during the first quarter valued at approximately $29,000. Allworth Financial LP raised its stake in shares of Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company’s stock valued at $32,000 after buying an additional 287 shares in the last quarter. National Bank of Canada FI acquired a new stake in shares of Doximity during the 1st quarter worth about $33,000. Spire Wealth Management grew its holdings in Doximity by 73.2% during the 1st quarter. Spire Wealth Management now owns 615 shares of the company’s stock worth $36,000 after acquiring an additional 260 shares during the last quarter. Finally, Brooklyn Investment Group boosted its stake in shares of Doximity by 70.7% in the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company’s stock valued at $43,000 after purchasing an additional 309 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors.

Doximity Stock Up 0.0%

Shares of NASDAQ DOCS opened at $69.55 on Wednesday. Doximity, Inc. has a 52 week low of $36.12 and a 52 week high of $85.21. The business has a 50-day simple moving average of $63.05 and a two-hundred day simple moving average of $59.88. The company has a market cap of $13.03 billion, a P/E ratio of 69.55, a P/E/G ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The company’s revenue was up 15.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities research analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. Canaccord Genuity Group lifted their price objective on shares of Doximity from $50.00 to $59.00 and gave the stock a “hold” rating in a research note on Friday, August 8th. Zacks Research cut shares of Doximity from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. William Blair reaffirmed an “outperform” rating on shares of Doximity in a research note on Friday, May 16th. Piper Sandler upped their price objective on Doximity from $65.00 to $69.00 and gave the company an “overweight” rating in a research note on Monday, August 11th. Finally, KeyCorp increased their target price on shares of Doximity from $65.00 to $70.00 and gave the company an “overweight” rating in a research report on Monday, July 14th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, Doximity presently has an average rating of “Moderate Buy” and an average price target of $66.21.

Insiders Place Their Bets

In other news, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction on Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the transaction, the director owned 16,618 shares in the company, valued at $948,721.62. The trade was a 10.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Timothy S. Cabral sold 10,000 shares of the company’s stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the completion of the sale, the director owned 6,360 shares of the company’s stock, valued at approximately $381,600. The trade was a 61.12% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,000 shares of company stock valued at $1,929,380. 31.30% of the stock is currently owned by corporate insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.